Kolltan Pharmaceuticals Obtains $25,000,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e055984e-af6f-49ee-b118-3835787cd2b4&Preview=1
Date
3/8/2012
Company Name
Kolltan Pharmaceuticals
Mailing Address
300 George St New Haven, CT 06511
Company Description
Kolltan is a development-stage company advancing therapeutics that target well-defined and validated molecular mechanisms of disease in areas of critical clinical need.
Website
http://www.kolltan.com
Transaction Type
Venture Equity
Transaction Amount
$25,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed